http://www.veracyte.com
Veracyte, Inc. Company Intro
A Message from Veracyte’s CEO About COVID-19
Industry
Healthcare
Veracyte, Inc. Headquaters
6000 Shoreline Court
South San Francisco,94080
United States
Veracyte, Inc. Share price
17 May 2023 14:04 GMT
$24.73
0.15 (0.61 %)
Veracyte, Inc. Market cap
$1.737 B
WMC RANKING
2023
Veracyte, Inc. # 50
BiotechnologyLatest Veracyte, Inc. News
02 Oct 2023
FDx Advisors Inc. Buys New Stake in Veracyte, Inc.
Veracyte, Inc. is a worldwide diagnostics company. They offer various genomic sequencing classifiers and tests to diagnose diseases such as prostate cancer,...
02 Oct 2023
New Stake in Veracyte, Inc. (NASDAQ:VCYT) Acquired by FDx ...
Veracyte, Inc. is a diagnostics company that offers various diagnostic tests for conditions such as prostate cancer, breast cancer, lung cancer, and...
02 Oct 2023
Veracyte, Inc. (NASDAQ:VCYT) Stock Holdings Raised by ...
Veracyte, Inc. (NASDAQ:VCYT) Stock Holdings Raised by Bank Julius Baer & Co. Ltd Zurich · Veracyte logo · In other news, Director John L. Bishop sold 10,000...
WMC Market Score
WMC Market to Revenue Score
Veracyte, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Veracyte, Inc. | USD | $123,064 | $150,053 | $-65,061 | $17,370B | 50 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Veracyte, Inc. Social Followers vs Top 4 Industry Competitors
Veracyte, Inc. Post vs Top 4 Industry Competitors
Veracyte, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Veracyte, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Veracyte, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Veracyte, Inc. | 1.34 | 0.70 | 0.05 | 0 | 0 | 0 | 0.32 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
